BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36682577)

  • 1. Diagnostic and prognostic value of plasma cell-free DNA combined with VEGF-C in laryngeal squamous cell carcinoma.
    Huang Q; Ji M; Li F; Li Y; Zhou X; Hsueh CY; Zhou L
    Mol Cell Probes; 2023 Feb; 67():101895. PubMed ID: 36682577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
    Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
    Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
    Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
    Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
    Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
    Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dickkopf-1 is a novel prognostic biomarker for laryngeal squamous cell carcinoma.
    Shi Y; Gong HL; Zhou L; Tian J; Wang Y
    Acta Otolaryngol; 2014 Jul; 134(7):753-9. PubMed ID: 24834937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating free DNA integrity index and promoter methylation of tumor suppressor gene P16, DAPK and RASSF1A as a biomarker for oropharyngeal squamous cell carcinoma.
    Kumari S; Mishra S; Anand N; Hadi R; Rastogi M; Husain N
    Pathol Res Pract; 2023 Jun; 246():154489. PubMed ID: 37150134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of coagulation markers in the progression and metastasis of laryngeal squamous cell carcinoma.
    Huang Q; Chen J; Huang Y; Xiong Y; Zhou J; Zhang Y; Lu M; Hu W; Zheng F; Zheng C
    BMC Cancer; 2023 Sep; 23(1):901. PubMed ID: 37749514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The level and integrity of plasma circulating cell-free DNA in patients with primary multiple myeloma.
    Shen Q; Cen H; Jiang J; Cong Z; Zhou Y; Huang X; Zhu L; Jiang Q; Xue C
    Transl Cancer Res; 2022 Nov; 11(11):4137-4147. PubMed ID: 36523306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.
    Wang JL; Wang X; Yang D; Shi WJ
    Yonsei Med J; 2016 Mar; 57(2):298-305. PubMed ID: 26847279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer.
    Ren S; Zeng G; Yi Y; Liu L; Tu H; Chai T; Hu L
    Heliyon; 2023 Oct; 9(10):e20851. PubMed ID: 37860559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
    Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
    Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study.
    Rapado-González Ó; López-Cedrún JL; Lago-Lestón RM; Abalo A; Rubin-Roger G; Salgado-Barreira Á; López-López R; Muinelo-Romay L; Suárez-Cunqueiro MM
    J Oral Pathol Med; 2022 May; 51(5):429-435. PubMed ID: 35416334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Efficacy Evaluation Comparison of cfDNA and CEA in Colorectal Cancer.
    Yu D; An G; Xu L
    Clin Lab; 2016 Oct; 62(10):1947-1953. PubMed ID: 28164530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
    Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
    Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating cell-free DNA variables as marker of ovarian cancer patients: A pilot study.
    Stamenkovic S; Cheng J; Surowy H; Burwinkel B; Gündert M
    Cancer Biomark; 2020; 28(2):159-167. PubMed ID: 32176629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of FoxP3, M2 (sCD163) and IGF-1 as potential biomarkers associated with Laryngeal Squamous Cell Carcinoma in Tunisian patients.
    Mokni Baizig N; Ben ElHadj M; Hsairi M; Fourati A; Kamoun S; Houcine Y; Gritli S; Driss M
    J Immunoassay Immunochem; 2024 Mar; 45(2):79-92. PubMed ID: 37936281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma.
    Shen Z; Cao B; Lin L; Zhou C; Ye D; Qiu S; Li Q; Cui X
    Med Sci Monit; 2017 Jul; 23():3635-3640. PubMed ID: 28743857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
    Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
    Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
    Fang R; Huang Y; Xie J; Zhang J; Ji X
    Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients.
    Agostini M; Enzo MV; Bedin C; Belardinelli V; Goldin E; Del Bianco P; Maschietto E; D'Angelo E; Izzi L; Saccani A; Zavagno G; Nitti D
    Cancer Biomark; 2012; 11(2-3):89-98. PubMed ID: 23011155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.